ORAGENICS (OGEN) CFO reports initial holdings, including 10,000-share stock option grant
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ORAGENICS INC Chief Financial Officer John Spencer filed an initial Form 3 reporting his beneficial ownership in company securities. The filing shows indirect ownership of 53 shares of common stock held by his spouse, and an employee stock option for 10,000 shares of common stock.
The option has an exercise price of $0.93 per share and expires on December 11, 2035. According to the award terms, one third of the options vest on the first anniversary of the grant date, with the remaining two thirds vesting in equal annual installments over the second and third anniversaries, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Spencer John
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 10,000 shares (Direct, null);
Common Stock — 53 shares (Indirect, By Spouse)
Footnotes (1)
- [object Object]
Key Figures
Indirect common shares: 53 shares
Stock option size: 10,000 shares
Option exercise price: $0.93 per share
+1 more
4 metrics
Indirect common shares
53 shares
Indirect ownership by spouse, common stock
Stock option size
10,000 shares
Employee Stock Option (right to buy) underlying common shares
Option exercise price
$0.93 per share
Exercise price for employee stock option
Option expiration
December 11, 2035
Expiration date of stock option grant
Key Terms
Form 3, Employee Stock Option (right to buy), 2021 Equity Incentive Plan, vesting, +1 more
5 terms
Form 3 regulatory
"Chief Financial Officer John Spencer filed an initial Form 3 reporting his beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Employee Stock Option (right to buy) financial
"security_title: Employee Stock Option (right to buy) with underlying common stock"
2021 Equity Incentive Plan financial
"Represents an award of options to purchase shares under the Company's 2021 Equity Incentive Plan, as amended"
vesting financial
"One third of the options vest on the first anniversary, with the remainder vesting over the second and third anniversaries"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"The option exercise price is the Company's closing price on the date of grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What does the Form 3 filing by ORAGENICS INC (OGEN) CFO John Spencer show?
The Form 3 shows John Spencer’s initial beneficial ownership in ORAGENICS securities, including 53 common shares held indirectly through his spouse and an employee stock option for 10,000 common shares with a $0.93 exercise price and long-dated expiration.
Is John Spencer’s stock option in ORAGENICS (OGEN) a new acquisition or a reported holding?
In this Form 3, the 10,000-share stock option is reported as a holding rather than a new transaction. The footnote explains it represents an award under the 2021 Equity Incentive Plan with a multi-year vesting schedule tied to continued service.
How does the vesting schedule work for John Spencer’s ORAGENICS (OGEN) stock options?
One third of the 10,000 options vest on the first anniversary of the grant date. The remaining options vest in equal annual installments over the second and third anniversaries, provided John Spencer continues performing services for ORAGENICS through each vesting date.